- Lobbying
- antimicrobial AND innovation AND alliance
Lobbying Arrangements Results for 'Antimicrobial Innovation Alliance'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Johnson & Johnson
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Astellas Pharma US, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
The Medicines Company
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Zavante Therapeutics, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Merck & Co., Inc.
Client manufacturers and develops pharmaceuticals, vaccines and biologic therapies. |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015" language in - H.R.6 - 21st Century Cures Act. |
Allergan, Plc.
Allergan is a diversified global pharmaceutical company |
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Microbion Corporation
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
AstraZeneca
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
GlaxoSmithKline
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Issues related to the development of critical need antimicrobial biopharmaceuticals. |
Antimicrobial Innovation Alliance
|
Forbes-Tate | |||
Details Development of policies to advance the antimicrobial research and novel product development environment, including advancing new market incentives. Medicare payment for inpatient antibiotics. |
Antimicrobial Innovation Alliance
|
THE MCMANUS GROUP | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Spero Opco, Inc.
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Development of policies to advance the antimicrobial research and development environment. Support of H.R.512 - DISARM Act of 2015 language in - H.R.6 - 21st Century Cures Act. |
Tetraphase Pharmaceuticals
|
The McManus Group, DBA Antimicrobial Innovation Alliance | |||
Details Access and reimbursement of drugs in Medicare Parts B and D. Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022 Issues related to reforming and i... |
Gilead Sciences, Inc.
|
THE MCMANUS GROUP |